Annual Report and Accounts 2010/11 - Cancer Research UK
Annual Report and Accounts 2010/11 - Cancer Research UK
Annual Report and Accounts 2010/11 - Cancer Research UK
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Our governance, structure <strong>and</strong> management <br />
(continued)<br />
Our Executive Board<br />
The Executive Directors who were members of the Executive<br />
Board during the year <strong>and</strong> as at 27 June 20<strong>11</strong> were:<br />
Harpal Kumar MA MEng MBA<br />
Chief Executive (Chair of Executive Board <strong>and</strong><br />
Scientific Executive Board)<br />
Harpal joined <strong>Cancer</strong> <strong>Research</strong> Technology Limited as Chief<br />
Executive in 2002. In addition to this role, he became Chief<br />
Operating Officer of <strong>Cancer</strong> <strong>Research</strong> <strong>UK</strong> in July 2004, before<br />
becoming Chief Executive in April 2007. Harpal is Chairman of<br />
the Beatson Institute for <strong>Cancer</strong> <strong>Research</strong> <strong>and</strong> is a Trustee of<br />
the Institute for <strong>Cancer</strong> <strong>Research</strong>. He also serves on the Boards<br />
of the National <strong>Cancer</strong> <strong>Research</strong> Institute <strong>and</strong> the <strong>UK</strong> Clinical<br />
<strong>Research</strong> Collaboration. He co-chairs the National Awareness<br />
<strong>and</strong> Early Diagnosis Initiative <strong>and</strong> is Deputy Chair of the<br />
Advisory Board for the <strong>Cancer</strong> Reform Strategy in Engl<strong>and</strong>.<br />
Aisling Burn<strong>and</strong> MBE<br />
Executive Director, Policy <strong>and</strong> Public Affairs<br />
Aisling joined the Charity in October 2009. She is responsible<br />
for keeping cancer on the political agenda across the <strong>UK</strong> <strong>and</strong><br />
in Europe. This includes developing our policies on cancer,<br />
science <strong>and</strong> charity issues, influencing politicians <strong>and</strong> civil<br />
servants <strong>and</strong> campaigning alongside our supporters to<br />
positively influence the issues which matter to patients.<br />
Iain Foulkes PhD<br />
Executive Director, Strategy <strong>and</strong> Planning<br />
Iain was appointed as the Executive Director, Strategy <strong>and</strong><br />
Planning in August 2009. He is responsible for helping to<br />
shape the long-term strategic direction of the organisation<br />
<strong>and</strong> to ensure we have effective strategies to meet our<br />
ambitious goals.<br />
Professor Peter Johnson MA MD FRCP<br />
Chief Clinician<br />
Peter is Chief Clinician for <strong>Cancer</strong> <strong>Research</strong> <strong>UK</strong>. He has<br />
responsibility for the strategy <strong>and</strong> shape of the Charity’s clinical<br />
activities, both in clinical research <strong>and</strong> in the wider context of<br />
cancer prevention, diagnosis <strong>and</strong> treatment.<br />
Professor Nic Jones PhD<br />
Chief Scientist<br />
Nic joined <strong>Cancer</strong> <strong>Research</strong> <strong>UK</strong> in February 20<strong>11</strong> as Chief<br />
Scientist. He is responsible for helping to develop our scientific<br />
strategy, ensuring that it is leading-edge <strong>and</strong> monitoring its<br />
implementation. He is Director of the Manchester <strong>Cancer</strong><br />
<strong>Research</strong> Centre <strong>and</strong> was previously Director of the Paterson<br />
Institute in Manchester.<br />
Sarah Lyness MA<br />
Executive Director, Communications <strong>and</strong> Information<br />
Sarah joined the Imperial <strong>Cancer</strong> <strong>Research</strong> Fund in 1997.<br />
She developed <strong>and</strong> launched the <strong>Cancer</strong> <strong>Research</strong> <strong>UK</strong> br<strong>and</strong><br />
in 2002, building it to be the most loved <strong>UK</strong> charity br<strong>and</strong>.<br />
She joined the Board, first as co-Director of Fundraising <strong>and</strong><br />
Marketing before taking responsibility for communicating<br />
with <strong>and</strong> informing people about cancer <strong>and</strong> the work of<br />
<strong>Cancer</strong> <strong>Research</strong> <strong>UK</strong>.<br />
Lynne Robb BSc ACA<br />
Chief Financial Officer <strong>and</strong> Executive Director,<br />
Corporate Resources<br />
Lynne joined <strong>Cancer</strong> <strong>Research</strong> <strong>UK</strong> as Finance Director in 2002.<br />
Her role has exp<strong>and</strong>ed to become Chief Financial Officer <strong>and</strong><br />
Executive Director of Corporate Resources, which includes<br />
Property, Finance, Treasury <strong>and</strong> Procurement for the<br />
organisation.<br />
Elizabeth Sideris BA MSc<br />
Executive Director, Human Resources<br />
Elizabeth Sideris was appointed as the Executive Director<br />
for Human Resources in August 2009. She is responsible<br />
for supporting the Charity in delivering the people related<br />
agenda <strong>and</strong> for facilitating the development of a performance<br />
<strong>and</strong> learning culture to enable the Charity to achieve its<br />
strategic objectives.<br />
Peter Sneddon PhD BSc DPhil(Oxon) <br />
Executive Director, <strong>Research</strong> Operations <strong>and</strong> Funding<br />
Peter joined the Charity in December 2008. He is responsible<br />
for the funding of our broad range of basic, translational <strong>and</strong><br />
clinical research. This includes all of our research funding<br />
committees <strong>and</strong> the funding of our Institutes, Centres <strong>and</strong><br />
Drug Development Office.<br />
Richard C Taylor<br />
Executive Director, Fundraising <strong>and</strong> Supporter Marketing<br />
Richard joined the Imperial <strong>Cancer</strong> <strong>Research</strong> Fund as Retail<br />
Director in April 1998. He is responsible for the five-year<br />
fundraising strategy which drives income to support the<br />
Charity’s long-term ambitions.<br />
For more information on our Executive Board<br />
<strong>and</strong> their full biographies please visit<br />
aboutus.cancerresearchuk.org/executive-board<br />
Clare Shepherd BA<br />
General Counsel<br />
Clare joined <strong>Cancer</strong> <strong>Research</strong> <strong>UK</strong> as Interim Legal Director<br />
in 2009. In February 20<strong>11</strong> she was appointed to the newlycreated<br />
role of General Counsel. Clare is responsible for the<br />
Charity’s assurance activities including Legal, Risk Management,<br />
Health <strong>and</strong> Safety, Internal Audit <strong>and</strong> Secretariat. The General<br />
Counsel is not a member of the Executive Board but<br />
attends Executive Board meetings.<br />
22 / <strong>Annual</strong> <strong>Report</strong> <strong>and</strong> <strong>Accounts</strong> / Our governance, structure <strong>and</strong> management